France's Sanofi to buy US biopharma firm Kadmon in US$1.9b deal

Published Wed, Sep 8, 2021 · 05:27 AM

    DeeperDive is a beta AI feature. Refer to full articles for the facts.

    [PARIS] French drugmaker Sanofi SA has agreed to buy U.S. biopharmaceutical company Kadmon Holdings Inc in a US$1.9 billion deal, the companies said on Wednesday.

    Sanofi said it has offered US$9.50 per share in cash for Kadmon, representing a total equity value of approximately US$1.9 billion on a fully diluted basis, and that both companies' boards unanimously approved the transaction.

    REUTERS

    Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.

    Share with us your feedback on BT's products and services